Stay updated on ABP798 vs Rituximab in NHL: Clinical Trial

Sign up to get notified when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP798 vs Rituximab in NHL: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study record for the completed ABP 798 versus rituximab trial in follicular non-Hodgkin lymphoma is available, including its design, outcome measures, locations, and participant-data sharing details.
    Difference
    100%
    Check dated 2026-11-12T15:11:34.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-29T15:32:14.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates about the transition from “Artificial Intelligence” to “Super Intelligence.” The study record still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-22T15:38:53.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-15T15:23:48.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1; the 403 error page is otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-08T15:56:50.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Access to the page now shows a 403 Forbidden error with the corresponding HTML header and a Home link. This replaces the previously visible study details and related Amgen-derived content.
    Difference
    19%
    Check dated 2026-09-24T21:50:41.000Z thumbnail image

Stay in the know with updates to ABP798 vs Rituximab in NHL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.